Last news
Junshi Biosciences Announces Publication of Results from TORCHLIGHT, a Randomized Phase 3 Trial of Toripalimab for the Treatment of Metastatic or Recurrent Triple-negative Breast Cancer in Nature Medicine

Junshi Biosciences Announces Publication of Results from TORCHLIGHT, a Randomized Phase 3 Trial of Toripalimab for the Treatment of Metastatic or Recurrent Triple-negative Breast Cancer in Nature Medicine

...

Verisk Names Doug Caccese and Saurabh Khemka Co-Presidents of Underwriting Solutions

Verisk Names Doug Caccese and Saurabh Khemka Co-Presidents of Underwriting Solutions

...

Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial Experience

Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial Experience

...

Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023

Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023

...

QuEra Computing Releases a Groundbreaking Roadmap for Advanced Error-Corrected Quantum Computers, Pioneering the Next Frontier in Quantum Innovation

QuEra Computing Releases a Groundbreaking Roadmap for Advanced Error-Corrected Quantum Computers, Pioneering the Next Frontier in Quantum Innovation

...

Institutional Investors’ Enthusiasm Grows for Innovative Private Equity Fund

Institutional Investors’ Enthusiasm Grows for Innovative Private Equity Fund

...

CNH streamlines Senior Leadership structure

CNH streamlines Senior Leadership structure

...

IceMOS Technology Raises Pre-IPO Funding Following Northern Ireland Investment Summit

IceMOS Technology Raises Pre-IPO Funding Following Northern Ireland Investment Summit

...

1 ... 179 180 181 182 183 184 185 186 187 ... 663
menu
menu